Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08864_nanopub.RA5F_W69oGazf8IVqj_IP9jazoX-nXbDjduPfMTsKKeJI#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB08864 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08864 label "Rilpivirine [drugbank:DB08864]" assertion.
- drugbank:DB08864 seeAlso DB08864 assertion.
- drugbank:DB08864 seeAlso rilpivirine.html assertion.
- drugbank:DB08864 seeAlso edurant-drug.htm assertion.
- drugbank:DB08864 identifier "drugbank:DB08864" assertion.
- drugbank:DB08864 description "Rilpivirine is non-nucleoside reverse transcriptase inhibitor (NNRTI) which is used for the treatment of HIV-1 infections in treatment-naive patients. It is a diarylpyrimidine, a class of molecules that resemble pyrimidine nucleotides found in DNA. Because of its flexible chemical structure, resistance of rilpivirine is less likely to develop than other NNRTI's. FDA approved on May 20, 2011." assertion.
- drugbank:DB08864 title "Rilpivirine" assertion.
- drugbank:DB08864 bio2rdf_vocabulary:identifier "DB08864" assertion.
- drugbank:DB08864 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08864 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08864" assertion.
- drugbank:DB08864 bio2rdf_vocabulary:x-identifiers.org DB08864 assertion.
- drugbank:DB08864 drugbank_vocabulary:drugbank-id "DB08864" assertion.
- drugbank:DB08864 drugbank_vocabulary:x-cas cas:500287-72-9 assertion.
- drugbank:DB08864 drugbank_vocabulary:x-ahfs ahfs:8:18.08.16 assertion.
- drugbank:DB08864 drugbank_vocabulary:x-atc atc:J05AG05 assertion.
- drugbank:DB08864 drugbank_vocabulary:x-chebi chebi:68606 assertion.
- drugbank:DB08864 drugbank_vocabulary:x-kegg kegg:D09720 assertion.
- drugbank:DB08864 drugbank_vocabulary:x-wikipedia wikipedia:Rilpivirine assertion.
- drugbank:DB08864 drugbank_vocabulary:x-ndc ndc:59676-278-01 assertion.